Industry Research Reports

Home > Reports > New Technology > Global Chip-based Oligonucleotide Synthesis Market Insights, Forecast to 2030

Global Chip-based Oligonucleotide Synthesis Market Insights, Forecast to 2030

Industry: New Technology

Published: 2024-11-12

Pages: 127 Pages

Report ld: 3373614

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global Chip-based Oligonucleotide Synthesis market is projected to grow from US$ 41 million in 2024 to US$ 146 million by 2030, at a Compound Annual Growth Rate (CAGR) of 23.6% during the forecast period.

Chip-based oligonucleotide synthesis is a high-throughput, cost-effective method utilizing microarray chips to mass-produce short DNA or RNA fragments. Compared to traditional synthesis methods, this technology offers faster speed, higher precision, and greater flexibility, making it especially suitable for fields like gene editing, synthetic biology, and genome sequencing. By enabling parallel synthesis, researchers can simultaneously produce thousands to millions of different oligonucleotide sequences on a single chip, significantly improving experimental efficiency and data output, thereby accelerating research and applications in the life sciences.

Chip-based Oligonucleotide Synthesis Market Size

M= millions and B=billions

The US & Canada market for Chip-based Oligonucleotide Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The China market for Chip-based Oligonucleotide Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The Europe market for Chip-based Oligonucleotide Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key manufacturers of Chip-based Oligonucleotide Synthesis include Thermo Fisher, GenScript, LC Sciences, Twist Bioscience, Agilent Technologies, Evonetix, Dynegene Technologies, LC-Bio Technologies, Atantares, BGI Genomics, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Includes
This report presents an overview of global market for Chip-based Oligonucleotide Synthesis market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Chip-based Oligonucleotide Synthesis, also provides the revenue of main regions and countries. of the upcoming market potential for Chip-based Oligonucleotide Synthesis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Chip-based Oligonucleotide Synthesis revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Chip-based Oligonucleotide Synthesis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Chip-based Oligonucleotide Synthesis revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Thermo Fisher, GenScript, LC Sciences, Twist Bioscience, Agilent Technologies, Evonetix, Dynegene Technologies, LC-Bio Technologies, Atantares, BGI Genomics, etc.

Market Segmentation

Report Metric
Details
Report Title
Global Chip-based Oligonucleotide Synthesis Market Insights, Forecast to 2030
Forecasted Market Size in 2030
US$ 146 million
CAGR(2024-2030)
23.6%
Market Size Available for Years
2019-2030
Global Chip-based Oligonucleotide Synthesis Companies Covered
Thermo Fisher, GenScript, LC Sciences, Twist Bioscience, Agilent Technologies, Evonetix, Dynegene Technologies, LC-Bio Technologies, Atantares, BGI Genomics
Global Chip-based Oligonucleotide Synthesis Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Chip-based Oligonucleotide Synthesis Market, Segment by Type
Photochemical Method

Electrochemical Method

Inkjet Printing Method
Global Chip-based Oligonucleotide Synthesis Market, Segment by Application
Scientific Research

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Chip-based Oligonucleotide Synthesis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chip-based Oligonucleotide Synthesis companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Chip-based Oligonucleotide Synthesis revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

 1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Chip-based Oligonucleotide Synthesis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
        1.2.2 Photochemical Method
        1.2.3 Electrochemical Method
        1.2.4 Inkjet Printing Method
    1.3 Market by Application
        1.3.1 Global Chip-based Oligonucleotide Synthesis Market Share by Application: 2019 VS 2023 VS 2030
        1.3.2 Scientific Research
        1.3.3 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global Chip-based Oligonucleotide Synthesis Market Perspective (2019-2030)
    2.2 Global Chip-based Oligonucleotide Synthesis Growth Trends by Region
        2.2.1 Global Chip-based Oligonucleotide Synthesis Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Chip-based Oligonucleotide Synthesis Historic Market Size by Region (2019-2024)
        2.2.3 Chip-based Oligonucleotide Synthesis Forecasted Market Size by Region (2025-2030)
    2.3 Chip-based Oligonucleotide Synthesis Market Dynamics
        2.3.1 Chip-based Oligonucleotide Synthesis Industry Trends
        2.3.2 Chip-based Oligonucleotide Synthesis Market Drivers
        2.3.3 Chip-based Oligonucleotide Synthesis Market Challenges
        2.3.4 Chip-based Oligonucleotide Synthesis Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Revenue Chip-based Oligonucleotide Synthesis by Players
        3.1.1 Global Chip-based Oligonucleotide Synthesis Revenue by Players (2019-2024)
        3.1.2 Global Chip-based Oligonucleotide Synthesis Revenue Market Share by Players (2019-2024)
    3.2 Global Chip-based Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players of Chip-based Oligonucleotide Synthesis, Ranking by Revenue, 2022 VS 2023 VS 2024
    3.4 Global Chip-based Oligonucleotide Synthesis Market Concentration Ratio
        3.4.1 Global Chip-based Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Chip-based Oligonucleotide Synthesis Revenue in 2023
    3.5 Global Key Players of Chip-based Oligonucleotide Synthesis Head office and Area Served
    3.6 Global Key Players of Chip-based Oligonucleotide Synthesis, Product and Application
    3.7 Global Key Players of Chip-based Oligonucleotide Synthesis, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

 4 Chip-based Oligonucleotide Synthesis Breakdown Data by Type
    4.1 Global Chip-based Oligonucleotide Synthesis Historic Market Size by Type (2019-2024)
    4.2 Global Chip-based Oligonucleotide Synthesis Forecasted Market Size by Type (2025-2030)

 5 Chip-based Oligonucleotide Synthesis Breakdown Data by Application
    5.1 Global Chip-based Oligonucleotide Synthesis Historic Market Size by Application (2019-2024)
    5.2 Global Chip-based Oligonucleotide Synthesis Forecasted Market Size by Application (2025-2030)

 6 North America
    6.1 North America Chip-based Oligonucleotide Synthesis Market Size (2019-2030)
    6.2 North America Chip-based Oligonucleotide Synthesis Market Size by Type
        6.2.1 North America Chip-based Oligonucleotide Synthesis Market Size by Type (2019-2024)
        6.2.2 North America Chip-based Oligonucleotide Synthesis Market Size by Type (2025-2030)
        6.2.3 North America Chip-based Oligonucleotide Synthesis Market Share by Type (2019-2030)
    6.3 North America Chip-based Oligonucleotide Synthesis Market Size by Application
        6.3.1 North America Chip-based Oligonucleotide Synthesis Market Size by Application (2019-2024)
        6.3.2 North America Chip-based Oligonucleotide Synthesis Market Size by Application (2025-2030)
        6.3.3 North America Chip-based Oligonucleotide Synthesis Market Share by Application (2019-2030)
    6.4 North America Chip-based Oligonucleotide Synthesis Market Size by Country
        6.4.1 North America Chip-based Oligonucleotide Synthesis Market Size by Country: 2019 VS 2023 VS 2030
        6.4.2 North America Chip-based Oligonucleotide Synthesis Market Size by Country (2019-2024)
        6.4.3 North America Chip-based Oligonucleotide Synthesis Market Share by Country (2025-2030)
        6.4.4 United States
        6.4.5 Canada

 7 Europe
    7.1 Europe Chip-based Oligonucleotide Synthesis Market Size (2019-2030)
    7.2 Europe Chip-based Oligonucleotide Synthesis Market Size by Type
        7.2.1 Europe Chip-based Oligonucleotide Synthesis Market Size by Type (2019-2024)
        7.2.2 Europe Chip-based Oligonucleotide Synthesis Market Size by Type (2025-2030)
        7.2.3 Europe Chip-based Oligonucleotide Synthesis Market Share by Type (2019-2030)
    7.3 Europe Chip-based Oligonucleotide Synthesis Market Size by Application
        7.3.1 Europe Chip-based Oligonucleotide Synthesis Market Size by Application (2019-2024)
        7.3.2 Europe Chip-based Oligonucleotide Synthesis Market Size by Application (2025-2030)
        7.3.3 Europe Chip-based Oligonucleotide Synthesis Market Share by Application (2019-2030)
    7.4 Europe Chip-based Oligonucleotide Synthesis Market Size by Country
        7.4.1 Europe Chip-based Oligonucleotide Synthesis Market Size by Country: 2019 VS 2023 VS 2030
        7.4.2 Europe Chip-based Oligonucleotide Synthesis Market Size by Country (2019-2024)
        7.4.3 Europe Chip-based Oligonucleotide Synthesis Market Size by Country (2025-2030)
        7.4.4 Germany
        7.4.5 France
        7.4.6 U.K.
        7.4.7 Italy
        7.4.8 Russia
        7.4.9 Nordic Countries

 8 China
    8.1 China Chip-based Oligonucleotide Synthesis Market Size (2019-2030)
    8.2 China Chip-based Oligonucleotide Synthesis Market Size by Type
        8.2.1 China Chip-based Oligonucleotide Synthesis Market Size by Type (2019-2024)
        8.2.2 China Chip-based Oligonucleotide Synthesis Market Size by Type (2025-2030)
        8.2.3 China Chip-based Oligonucleotide Synthesis Market Share by Type (2019-2030)
    8.3 China Chip-based Oligonucleotide Synthesis Market Size by Application
        8.3.1 China Chip-based Oligonucleotide Synthesis Market Size by Application (2019-2024)
        8.3.2 China Chip-based Oligonucleotide Synthesis Market Size by Application (2025-2030)
        8.3.3 China Chip-based Oligonucleotide Synthesis Market Share by Application (2019-2030)

 9 Asia (excluding China)
    9.1 Asia Chip-based Oligonucleotide Synthesis Market Size (2019-2030)
    9.2 Asia Chip-based Oligonucleotide Synthesis Market Size by Type
        9.2.1 Asia Chip-based Oligonucleotide Synthesis Market Size by Type (2019-2024)
        9.2.2 Asia Chip-based Oligonucleotide Synthesis Market Size by Type (2025-2030)
        9.2.3 Asia Chip-based Oligonucleotide Synthesis Market Share by Type (2019-2030)
    9.3 Asia Chip-based Oligonucleotide Synthesis Market Size by Application
        9.3.1 Asia Chip-based Oligonucleotide Synthesis Market Size by Application (2019-2024)
        9.3.2 Asia Chip-based Oligonucleotide Synthesis Market Size by Application (2025-2030)
        9.3.3 Asia Chip-based Oligonucleotide Synthesis Market Share by Application (2019-2030)
    9.4 Asia Chip-based Oligonucleotide Synthesis Market Size by Region
        9.4.1 Asia Chip-based Oligonucleotide Synthesis Market Size by Region: 2019 VS 2023 VS 2030
        9.4.2 Asia Chip-based Oligonucleotide Synthesis Market Size by Region (2019-2024)
        9.4.3 Asia Chip-based Oligonucleotide Synthesis Market Size by Region (2025-2030)
        9.4.4 Japan
        9.4.5 South Korea
        9.4.6 China Taiwan
        9.4.7 Southeast Asia
        9.4.8 India
        9.4.9 Australia

 10 Middle East, Africa, and Latin America
    10.1 Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size (2019-2030)
    10.2 Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size by Type
        10.2.1 Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size by Type (2019-2024)
        10.2.2 Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size by Type (2025-2030)
        10.2.3 Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Share by Type (2019-2030)
    10.3 Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size by Application
        10.3.1 Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size by Application (2019-2024)
        10.3.2 Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size by Application (2025-2030)
        10.3.3 Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Share by Application (2019-2030)
    10.4 Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size by Country
        10.4.1 Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size by Country: 2019 VS 2023 VS 2030
        10.4.2 Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size by Country (2019-2024)
        10.4.3 Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size by Country (2025-2030)
        10.4.4 Brazil
        10.4.5 Mexico
        10.4.6 Turkey
        10.4.7 Saudi Arabia
        10.4.8 Israel
        10.4.9 GCC Countries

 11 Key Players Profiles
    11.1 Thermo Fisher
        11.1.1 Thermo Fisher Company Details
        11.1.2 Thermo Fisher Business Overview
        11.1.3 Thermo Fisher Chip-based Oligonucleotide Synthesis Introduction
        11.1.4 Thermo Fisher Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024)
        11.1.5 Thermo Fisher Recent Development
    11.2 GenScript
        11.2.1 GenScript Company Details
        11.2.2 GenScript Business Overview
        11.2.3 GenScript Chip-based Oligonucleotide Synthesis Introduction
        11.2.4 GenScript Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024)
        11.2.5 GenScript Recent Development
    11.3 LC Sciences
        11.3.1 LC Sciences Company Details
        11.3.2 LC Sciences Business Overview
        11.3.3 LC Sciences Chip-based Oligonucleotide Synthesis Introduction
        11.3.4 LC Sciences Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024)
        11.3.5 LC Sciences Recent Development
    11.4 Twist Bioscience
        11.4.1 Twist Bioscience Company Details
        11.4.2 Twist Bioscience Business Overview
        11.4.3 Twist Bioscience Chip-based Oligonucleotide Synthesis Introduction
        11.4.4 Twist Bioscience Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024)
        11.4.5 Twist Bioscience Recent Development
    11.5 Agilent Technologies
        11.5.1 Agilent Technologies Company Details
        11.5.2 Agilent Technologies Business Overview
        11.5.3 Agilent Technologies Chip-based Oligonucleotide Synthesis Introduction
        11.5.4 Agilent Technologies Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024)
        11.5.5 Agilent Technologies Recent Development
    11.6 Evonetix
        11.6.1 Evonetix Company Details
        11.6.2 Evonetix Business Overview
        11.6.3 Evonetix Chip-based Oligonucleotide Synthesis Introduction
        11.6.4 Evonetix Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024)
        11.6.5 Evonetix Recent Development
    11.7 Dynegene Technologies
        11.7.1 Dynegene Technologies Company Details
        11.7.2 Dynegene Technologies Business Overview
        11.7.3 Dynegene Technologies Chip-based Oligonucleotide Synthesis Introduction
        11.7.4 Dynegene Technologies Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024)
        11.7.5 Dynegene Technologies Recent Development
    11.8 LC-Bio Technologies
        11.8.1 LC-Bio Technologies Company Details
        11.8.2 LC-Bio Technologies Business Overview
        11.8.3 LC-Bio Technologies Chip-based Oligonucleotide Synthesis Introduction
        11.8.4 LC-Bio Technologies Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024)
        11.8.5 LC-Bio Technologies Recent Development
    11.9 Atantares
        11.9.1 Atantares Company Details
        11.9.2 Atantares Business Overview
        11.9.3 Atantares Chip-based Oligonucleotide Synthesis Introduction
        11.9.4 Atantares Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024)
        11.9.5 Atantares Recent Development
    11.10 BGI Genomics
        11.10.1 BGI Genomics Company Details
        11.10.2 BGI Genomics Business Overview
        11.10.3 BGI Genomics Chip-based Oligonucleotide Synthesis Introduction
        11.10.4 BGI Genomics Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024)
        11.10.5 BGI Genomics Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Chip-based Oligonucleotide Synthesis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Photochemical Method
 Table 3. Key Players of Electrochemical Method
 Table 4. Key Players of Inkjet Printing Method
 Table 5. Global Chip-based Oligonucleotide Synthesis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Chip-based Oligonucleotide Synthesis Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Chip-based Oligonucleotide Synthesis Market Size by Region (2019-2024) & (US$ Million)
 Table 8. Global Chip-based Oligonucleotide Synthesis Market Share by Region (2019-2024)
 Table 9. Global Chip-based Oligonucleotide Synthesis Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 10. Global Chip-based Oligonucleotide Synthesis Market Share by Region (2025-2030)
 Table 11. Chip-based Oligonucleotide Synthesis Market Trends
 Table 12. Chip-based Oligonucleotide Synthesis Market Drivers
 Table 13. Chip-based Oligonucleotide Synthesis Market Challenges
 Table 14. Chip-based Oligonucleotide Synthesis Market Restraints
 Table 15. Global Chip-based Oligonucleotide Synthesis Revenue by Players (2019-2024) & (US$ Million)
 Table 16. Global Chip-based Oligonucleotide Synthesis Market Share by Players (2019-2024)
 Table 17. Global Top Chip-based Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chip-based Oligonucleotide Synthesis as of 2023)
 Table 18. Global Chip-based Oligonucleotide Synthesis Industry Ranking 2022 VS 2023
 Table 19. Global 5 Largest Players Market Share by Chip-based Oligonucleotide Synthesis Revenue (CR5 and HHI) & (2019-2024)
 Table 20. Global Key Players of Chip-based Oligonucleotide Synthesis, Headquarters and Area Served
 Table 21. Global Key Players of Chip-based Oligonucleotide Synthesis, Product and Application
 Table 22. Global Key Players of Chip-based Oligonucleotide Synthesis, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Chip-based Oligonucleotide Synthesis Market Size by Type (2019-2024) & (US$ Million)
 Table 25. Global Chip-based Oligonucleotide Synthesis Revenue Market Share by Type (2019-2024)
 Table 26. Global Chip-based Oligonucleotide Synthesis Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 27. Global Chip-based Oligonucleotide Synthesis Revenue Market Share by Type (2025-2030)
 Table 28. Global Chip-based Oligonucleotide Synthesis Market Size by Application (2019-2024) & (US$ Million)
 Table 29. Global Chip-based Oligonucleotide Synthesis Revenue Market Share by Application (2019-2024)
 Table 30. Global Chip-based Oligonucleotide Synthesis Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 31. Global Chip-based Oligonucleotide Synthesis Revenue Market Share by Application (2025-2030)
 Table 32. North America Chip-based Oligonucleotide Synthesis Market Size by Type (2019-2024) & (US$ Million)
 Table 33. North America Chip-based Oligonucleotide Synthesis Market Size by Type (2025-2030) & (US$ Million)
 Table 34. North America Chip-based Oligonucleotide Synthesis Market Size by Application (2019-2024) & (US$ Million)
 Table 35. North America Chip-based Oligonucleotide Synthesis Market Size by Application (2025-2030) & (US$ Million)
 Table 36. North America Chip-based Oligonucleotide Synthesis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 37. North America Chip-based Oligonucleotide Synthesis Market Size by Country (2019-2024) & (US$ Million)
 Table 38. North America Chip-based Oligonucleotide Synthesis Market Size by Country (2025-2030) & (US$ Million)
 Table 39. Europe Chip-based Oligonucleotide Synthesis Market Size by Type (2019-2024) & (US$ Million)
 Table 40. Europe Chip-based Oligonucleotide Synthesis Market Size by Type (2025-2030) & (US$ Million)
 Table 41. Europe Chip-based Oligonucleotide Synthesis Market Size by Application (2019-2024) & (US$ Million)
 Table 42. Europe Chip-based Oligonucleotide Synthesis Market Size by Application (2025-2030) & (US$ Million)
 Table 43. Europe Chip-based Oligonucleotide Synthesis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Europe Chip-based Oligonucleotide Synthesis Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Europe Chip-based Oligonucleotide Synthesis Market Size by Country (2025-2030) & (US$ Million)
 Table 46. China Chip-based Oligonucleotide Synthesis Market Size by Type (2019-2024) & (US$ Million)
 Table 47. China Chip-based Oligonucleotide Synthesis Market Size by Type (2025-2030) & (US$ Million)
 Table 48. China Chip-based Oligonucleotide Synthesis Market Size by Application (2019-2024) & (US$ Million)
 Table 49. China Chip-based Oligonucleotide Synthesis Market Size by Application (2025-2030) & (US$ Million)
 Table 50. Asia Chip-based Oligonucleotide Synthesis Market Size by Type (2019-2024) & (US$ Million)
 Table 51. Asia Chip-based Oligonucleotide Synthesis Market Size by Type (2025-2030) & (US$ Million)
 Table 52. Asia Chip-based Oligonucleotide Synthesis Market Size by Application (2019-2024) & (US$ Million)
 Table 53. Asia Chip-based Oligonucleotide Synthesis Market Size by Application (2025-2030) & (US$ Million)
 Table 54. Asia Chip-based Oligonucleotide Synthesis Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 55. Asia Chip-based Oligonucleotide Synthesis Market Size by Region (2019-2024) & (US$ Million)
 Table 56. Asia Chip-based Oligonucleotide Synthesis Market Size by Region (2025-2030) & (US$ Million)
 Table 57. Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size by Type (2019-2024) & (US$ Million)
 Table 58. Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size by Type (2025-2030) & (US$ Million)
 Table 59. Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size by Application (2019-2024) & (US$ Million)
 Table 60. Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size by Application (2025-2030) & (US$ Million)
 Table 61. Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 62. Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size by Country (2019-2024) & (US$ Million)
 Table 63. Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size by Country (2025-2030) & (US$ Million)
 Table 64. Thermo Fisher Company Details
 Table 65. Thermo Fisher Business Overview
 Table 66. Thermo Fisher Chip-based Oligonucleotide Synthesis Product
 Table 67. Thermo Fisher Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
 Table 68. Thermo Fisher Recent Development
 Table 69. GenScript Company Details
 Table 70. GenScript Business Overview
 Table 71. GenScript Chip-based Oligonucleotide Synthesis Product
 Table 72. GenScript Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
 Table 73. GenScript Recent Development
 Table 74. LC Sciences Company Details
 Table 75. LC Sciences Business Overview
 Table 76. LC Sciences Chip-based Oligonucleotide Synthesis Product
 Table 77. LC Sciences Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
 Table 78. LC Sciences Recent Development
 Table 79. Twist Bioscience Company Details
 Table 80. Twist Bioscience Business Overview
 Table 81. Twist Bioscience Chip-based Oligonucleotide Synthesis Product
 Table 82. Twist Bioscience Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
 Table 83. Twist Bioscience Recent Development
 Table 84. Agilent Technologies Company Details
 Table 85. Agilent Technologies Business Overview
 Table 86. Agilent Technologies Chip-based Oligonucleotide Synthesis Product
 Table 87. Agilent Technologies Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
 Table 88. Agilent Technologies Recent Development
 Table 89. Evonetix Company Details
 Table 90. Evonetix Business Overview
 Table 91. Evonetix Chip-based Oligonucleotide Synthesis Product
 Table 92. Evonetix Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
 Table 93. Evonetix Recent Development
 Table 94. Dynegene Technologies Company Details
 Table 95. Dynegene Technologies Business Overview
 Table 96. Dynegene Technologies Chip-based Oligonucleotide Synthesis Product
 Table 97. Dynegene Technologies Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
 Table 98. Dynegene Technologies Recent Development
 Table 99. LC-Bio Technologies Company Details
 Table 100. LC-Bio Technologies Business Overview
 Table 101. LC-Bio Technologies Chip-based Oligonucleotide Synthesis Product
 Table 102. LC-Bio Technologies Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
 Table 103. LC-Bio Technologies Recent Development
 Table 104. Atantares Company Details
 Table 105. Atantares Business Overview
 Table 106. Atantares Chip-based Oligonucleotide Synthesis Product
 Table 107. Atantares Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
 Table 108. Atantares Recent Development
 Table 109. BGI Genomics Company Details
 Table 110. BGI Genomics Business Overview
 Table 111. BGI Genomics Chip-based Oligonucleotide Synthesis Product
 Table 112. BGI Genomics Revenue in Chip-based Oligonucleotide Synthesis Business (2019-2024) & (US$ Million)
 Table 113. BGI Genomics Recent Development
 Table 114. Research Programs/Design for This Report
 Table 115. Key Data Information from Secondary Sources
 Table 116. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Chip-based Oligonucleotide Synthesis Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 2. Global Chip-based Oligonucleotide Synthesis Market Share by Type: 2023 VS 2030
 Figure 3. Photochemical Method Features
 Figure 4. Electrochemical Method Features
 Figure 5. Inkjet Printing Method Features
 Figure 6. Global Chip-based Oligonucleotide Synthesis Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 7. Global Chip-based Oligonucleotide Synthesis Market Share by Application: 2023 VS 2030
 Figure 8. Scientific Research Case Studies
 Figure 9. Others Case Studies
 Figure 10. Chip-based Oligonucleotide Synthesis Report Years Considered
 Figure 11. Global Chip-based Oligonucleotide Synthesis Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 12. Global Chip-based Oligonucleotide Synthesis Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Chip-based Oligonucleotide Synthesis Market Share by Region: 2023 VS 2030
 Figure 14. Global Chip-based Oligonucleotide Synthesis Market Share by Players in 2023
 Figure 15. Global Top Chip-based Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chip-based Oligonucleotide Synthesis as of 2023)
 Figure 16. The Top 10 and 5 Players Market Share by Chip-based Oligonucleotide Synthesis Revenue in 2023
 Figure 17. North America Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 18. North America Chip-based Oligonucleotide Synthesis Market Share by Type (2019-2030)
 Figure 19. North America Chip-based Oligonucleotide Synthesis Market Share by Application (2019-2030)
 Figure 20. North America Chip-based Oligonucleotide Synthesis Market Share by Country (2019-2030)
 Figure 21. United States Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Canada Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Chip-based Oligonucleotide Synthesis Market Share by Type (2019-2030)
 Figure 25. Europe Chip-based Oligonucleotide Synthesis Market Share by Application (2019-2030)
 Figure 26. Europe Chip-based Oligonucleotide Synthesis Market Share by Country (2019-2030)
 Figure 27. Germany Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. France Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. U.K. Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Italy Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Russia Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Nordic Countries Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. China Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. China Chip-based Oligonucleotide Synthesis Market Share by Type (2019-2030)
 Figure 35. China Chip-based Oligonucleotide Synthesis Market Share by Application (2019-2030)
 Figure 36. Asia Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Asia Chip-based Oligonucleotide Synthesis Market Share by Type (2019-2030)
 Figure 38. Asia Chip-based Oligonucleotide Synthesis Market Share by Application (2019-2030)
 Figure 39. Asia Chip-based Oligonucleotide Synthesis Market Share by Region (2019-2030)
 Figure 40. Japan Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. South Korea Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. China Taiwan Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Southeast Asia Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. India Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Australia Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Share by Type (2019-2030)
 Figure 48. Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Share by Application (2019-2030)
 Figure 49. Middle East, Africa, and Latin America Chip-based Oligonucleotide Synthesis Market Share by Country (2019-2030)
 Figure 50. Brazil Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 51. Mexico Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 52. Turkey Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 53. Saudi Arabia Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 54. Israel Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 55. GCC Countries Chip-based Oligonucleotide Synthesis Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 56. Thermo Fisher Revenue Growth Rate in Chip-based Oligonucleotide Synthesis Business (2019-2024)
 Figure 57. GenScript Revenue Growth Rate in Chip-based Oligonucleotide Synthesis Business (2019-2024)
 Figure 58. LC Sciences Revenue Growth Rate in Chip-based Oligonucleotide Synthesis Business (2019-2024)
 Figure 59. Twist Bioscience Revenue Growth Rate in Chip-based Oligonucleotide Synthesis Business (2019-2024)
 Figure 60. Agilent Technologies Revenue Growth Rate in Chip-based Oligonucleotide Synthesis Business (2019-2024)
 Figure 61. Evonetix Revenue Growth Rate in Chip-based Oligonucleotide Synthesis Business (2019-2024)
 Figure 62. Dynegene Technologies Revenue Growth Rate in Chip-based Oligonucleotide Synthesis Business (2019-2024)
 Figure 63. LC-Bio Technologies Revenue Growth Rate in Chip-based Oligonucleotide Synthesis Business (2019-2024)
 Figure 64. Atantares Revenue Growth Rate in Chip-based Oligonucleotide Synthesis Business (2019-2024)
 Figure 65. BGI Genomics Revenue Growth Rate in Chip-based Oligonucleotide Synthesis Business (2019-2024)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed

Description

The global Chip-based Oligonucleotide Synthesis market is projected to grow from US$ 41 million in 2024 to US$ 146 million by 2030, at a Compound Annual Growth Rate (CAGR) of 23.6% during the forecast period.

Chip-based oligonucleotide synthesis is a high-throughput, cost-effective method utilizing microarray chips to mass-produce short DNA or RNA fragments. Compared to traditional synthesis methods, this technology offers faster speed, higher precision, and greater flexibility, making it especially suitable for fields like gene editing, synthetic biology, and genome sequencing. By enabling parallel synthesis, researchers can simultaneously produce thousands to millions of different oligonucleotide sequences on a single chip, significantly improving experimental efficiency and data output, thereby accelerating research and applications in the life sciences.

The China market for Chip-based Oligonucleotide Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The Europe market for Chip-based Oligonucleotide Synthesis is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Market Segmentation